Literature DB >> 545833

The association of viruses with urveal melanoma.

D M Albert.   

Abstract

Electron microscopic examination of 57 ocular melanomas (54 human, two feline and one canine) revealed the presence of viral particles in six specimens. Herpesviruses particles were observed in one human specimen and were passed in human fibroblasts (WI-38), where they gave rise to intranuclear inclusions. A-type oncornavirus particles (oncogenic RNA virus) were observed in a second case, both in cells of tumor directly removed from an enucleated eye as well as in cells grown in tissue culture. In three human specimens and one feline specimen, togavirus particles were observed. Rubella is a member of this group, and the possibility that the presence of togavirus in these tumors is the result of latent ocular infection by rubella virus is raised. Herpes virus and RNA tumor viruses are widely considered as having a possible etiologic role for certain human cancers. The observation of togavirus is unexpected, as this virus has not been previously implicated in human or animal tumors. Injection of an RNA tumor virus (Gardner strain feline sarcoma virus) into the anterior chamber of newborn kittens resulted in the development of iris and ciliary body melanomas, many of which showed invasion and, in one instance, metastasis. This is the first animal model of a viral-induced uveal melanoma, and the histology and ultrastructure are described. These results emphasize the need for the continued investigation of the role of these viruses in uveal melanoma.

Entities:  

Mesh:

Year:  1979        PMID: 545833      PMCID: PMC1311713     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  197 in total

1.  The concept of virus.

Authors:  A LWOFF
Journal:  J Gen Microbiol       Date:  1957-10

2.  Electron microscopy of type 4 adenovirus strain R1-67.

Authors:  A J TOUSIMIS; M R HILLEMAN
Journal:  Virology       Date:  1957-12       Impact factor: 3.616

3.  Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture.

Authors:  W P ROWE; R J HUEBNER; L K GILMORE; R H PARROTT; T G WARD
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

Review 4.  Mycoplasmas and cell cultures.

Authors:  E Stanbridge
Journal:  Bacteriol Rev       Date:  1971-06

5.  Retinoblastoma-like tumors induced in rats by human adenovirus.

Authors:  S Kobayashi; N Mukai
Journal:  Invest Ophthalmol       Date:  1973-11

6.  Ultrastructural studies of feline leukemia virus.

Authors:  E Dougherty; C G Rickard
Journal:  J Ultrastruct Res       Date:  1970-09

7.  Neoplasms in mice inoculated with a tumor agent carried in tissue culture.

Authors:  S E STEWART; B E EDDY; N BORGESE
Journal:  J Natl Cancer Inst       Date:  1958-06       Impact factor: 13.506

8.  The nuclear envelope; its structure and relation to cytoplasmic membranes.

Authors:  M L WATSON
Journal:  J Biophys Biochem Cytol       Date:  1955-05-25

9.  The fine structure of annulate lamellae.

Authors:  H SWIFT
Journal:  J Biophys Biochem Cytol       Date:  1956-07-25

10.  Abnormal intranuclear and cytoplasmic formations associated with a chemically induced, transplantable chicken sarcoma.

Authors:  M F BINGGELI
Journal:  J Biophys Biochem Cytol       Date:  1959-01-25
View more
  3 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

2.  The occurrence and proposed significance of Schnabel cavernous degeneration in uveal melanoma.

Authors:  Mozhgan Rezaei Kanavi; Amir A Azari; Heather D Potter; Vivian Lee; Daniel M Albert
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

3.  Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas.

Authors:  J M Seddon; D T MacLaughlin; D M Albert; E S Gragoudas; M Ference
Journal:  Br J Ophthalmol       Date:  1982-11       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.